Laurion Capital Management LP
13F filer · CIK 1390202 · New York, NY
Summary
Laurion Capital Management LP reported $3.90B across 420 positions in its 13F for 2026 Q2, filed Aug 13, 2026. The largest holdings are SPY (5.2%), NSC (3.1%), EA (3.0%). Versus 2026 Q1, leaving options aside, it opened 158 new positions, added to 35, trimmed 48 and sold out of 94.
Reported value$3.90B
Positions420incl. options
Report period2026 Q2
FiledAug 13, 2026
New positions158
Added35
Trimmed48
Sold out94
Top 25 holdings
By reported value, options listed separately · change vs 2026 Q1
Weight 5.2%Value $201.63MPrice $765.61Shares 270KSince Jun 30 +2.52%
Weight 3.1%Value $120.91MPrice $313.05Shares 384K +9.30%Since Jun 30 -0.49%
Weight 3.0%Value $115.56MPrice $209.70Shares 564K -0.58%Since Jun 30 +2.27%
Weight 2.7%Value $104.91MPrice $30.90Shares 3.94M +26.51%Since Jun 30 +15.90%
Weight 2.6%Value $100.71MPrice $65.97Shares 1.35M +7.09%Since Jun 30 -11.43%
Weight 1.8%Value $69.41MPrice $177.18Shares 387KSince Jun 30 -1.34%
Weight 1.7%Value $67.62MPrice $25.63Shares 2.51M +12.28%Since Jun 30 -5.00%
Weight 1.1%Value $44.42MPrice $5.60Shares 7.82M -0.03%Since Jun 30 -1.41%
Weight 0.6%Value $23.57MPrice $187.48Shares 128KSince Jun 30 +1.46%
BRIDGEBIO PHARMA INCNo ticker matchHold
Weight 0.5%Value $21.22MPrincipal $19.10M
Weight 0.5%Value $17.79MPrice $44.07Shares 357K +58.62%Since Jun 30 -11.61%
NIO INCNo ticker matchHold
Weight 0.5%Value $17.55MPrincipal $17.50M
Weight 0.4%Value $16.41MPrice $36.59Shares 294K -58.03%Since Jun 30 -34.50%
INNIO NVNo ticker matchNew
Weight 0.4%Value $15.82MShares 400K
NIO INCNo ticker matchHold
Weight 0.4%Value $15.51MPrincipal $15.50M
Weight 0.4%Value $15.26MPrice $3.92Shares 2.00M +4.16%Since Jun 30 -48.56%
Weight 0.4%Value $14.75MPrice $2.90Shares 4.90M -1.93%Since Jun 30 -3.65%
Weight 0.4%Value $13.75MPrice $35.07Shares 349K +74.26%Since Jun 30 -11.08%
Weight 0.3%Value $13.02MPrice $509.22Shares 35K +1242.81%Since Jun 30 +36.51%
Weight 0.3%Value $12.52MPrice $60.47Shares 190KSince Jun 30 -8.13%
Weight 0.3%Value $11.89MPrice $264.58Shares 48K +864.05%Since Jun 30 +6.53%
Weight 0.3%Value $11.04MPrice $139.42Shares 68K +0.45%Since Jun 30 -14.40%
Weight 0.3%Value $10.61MPrice $263.29Shares 42K +402.30%Since Jun 30 +4.63%
Weight 0.3%Value $10.29MPrice $263.24Shares 47K +0.35%Since Jun 30 +19.20%
Weight 0.3%Value $9.94MPrice $116.46Shares 99K +192.29%Since Jun 30 +16.13%
| Stock | Weight | Value | Since Jun 30 | Shares change | Action |
|---|---|---|---|---|---|
| 5.2% | $201.63M | +2.52% | — | New | |
| 3.1% | $120.91M | -0.49% | +9.30% | Add | |
| 3.0% | $115.56M | +2.27% | -0.58% | Trim | |
| 2.7% | $104.91M | +15.90% | +26.51% | Add | |
| 2.6% | $100.71M | -11.43% | +7.09% | Add | |
| 1.8% | $69.41M | -1.34% | — | New | |
| 1.7% | $67.62M | -5.00% | +12.28% | Add | |
| 1.1% | $44.42M | -1.41% | -0.03% | Trim | |
| 0.6% | $23.57M | +1.46% | — | New | |
| BRIDGEBIO PHARMA INCNo ticker match | 0.5% | $21.22M | — | — | Hold |
| 0.5% | $17.79M | -11.61% | +58.62% | Add | |
| NIO INCNo ticker match | 0.5% | $17.55M | — | — | Hold |
| 0.4% | $16.41M | -34.50% | -58.03% | Trim | |
| INNIO NVNo ticker match | 0.4% | $15.82M | — | — | New |
| NIO INCNo ticker match | 0.4% | $15.51M | — | — | Hold |
| 0.4% | $15.26M | -48.56% | +4.16% | Add | |
| 0.4% | $14.75M | -3.65% | -1.93% | Trim | |
| 0.4% | $13.75M | -11.08% | +74.26% | Add | |
| 0.3% | $13.02M | +36.51% | +1242.81% | Add | |
| 0.3% | $12.52M | -8.13% | — | New | |
| 0.3% | $11.89M | +6.53% | +864.05% | Add | |
| 0.3% | $11.04M | -14.40% | +0.45% | Add | |
| 0.3% | $10.61M | +4.63% | +402.30% | Add | |
| 0.3% | $10.29M | +19.20% | +0.35% | Add | |
| 0.3% | $9.94M | +16.13% | +192.29% | Add |
Weight is the share of the reported 13F value, including options at notional value. “Since Jun 30” compares the latest close with the quarter-end price implied by the filing (value ÷ shares).
Largest buys in 2026 Q2
INNIO NVNo ticker match≈ $15.82MNew
Largest sells in 2026 Q2
Options
Notional value, listed apart from stocks · top 10 of 167
Source: SEC Form 13F, values as reported by the filer. Filings lag up to 45 days after quarter end and cover only certain long positions. Research only, not investment advice.